The Cancer Crisis We Can See Coming And Have the Tools to Change
Colon cancer has long been considered a disease that comes with old age. However, the…
The Cancer Crisis We Can See Coming And Have the Tools to Change
Colon cancer has long been considered a disease that comes with old age. However, the trend line of disease has been moving in the wrong direction for years, in a population we long assumed wasn’t at risk. And while researchers continue to investigate the why, there’s a parallel conversation we aren’t having nearly enough. One…
Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care
As radiopharmaceuticals continue to evolve, the convergence of scientific innovation, operational practicality, and clinical expertise is opening new possibilities in oncology. The post Precision Delivered: How Radiopharmaceuticals Are Reshaping Cancer Care appeared first on MedCity News.
The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience
Direct-to-patient (DTP) models create a continuous loop of value, connecting seamless patient and provider experience with the strategic power of branding and data. The post The Brand-Driven Flywheel: Igniting Growth Through a Simple Patient Experience appeared first on MedCity News.
Top Silicon Valley VCs Are Backing a New Health Tech Residency Program
The AI Health Fund launched Treehub, a new residency program designed to back and build healthcare AI startups at the earliest stages, often before companies are even formed. It is supported by prominent figures in the Silicon Valley venture capital world, including Tim Draper and Anne Wojcicki. The post Top Silicon Valley VCs Are Backing…
Regeneron Gets Landmark FDA Approval for First Gene Therapy for Hearing Loss
Regeneron Pharmaceuticals’ Otarmeni is now approved for treating hearing loss from an ultra-rare genetic mutation found in an estimated 50 newborns per year. While Regeneron will offer this gene therapy for free, the approval came with a rare pediatric disease priority review voucher that the company can sell for hundreds of millions of dollars. The…
SCAN CEO Urges Brokers to Drop Plans That Treat Them Poorly — One Says She Has No Choice
SCAN Health Plan CEO Sachin Jain urged brokers to abandon for-profit plans that treat them poorly, but one broker argued they often can’t because dominant players like UnitedHealth Group control so much of the healthcare system. The post SCAN CEO Urges Brokers to Drop Plans That Treat Them Poorly — One Says She Has No…
What We Know from the Latest PEPFAR Data: Analysis of FY 2025 Quarter 4 Results
This analysis examines the latest Monitoring, Evaluation, and Results (MER) data released by the PEPFAR program, the first glimpse of PEPFAR programming and outcomes for FY 2025.
MedCity Pivot Podcast: Modernizing Prior Auth
[Sponsored] In this episode, MedCity News’ Arundhati Parmar chats with a pharmacy benefits leader and a virtual pharmacy operator about ways to modernize and scale prior authorization. The post MedCity Pivot Podcast: Modernizing Prior Auth appeared first on MedCity News.
Adrian Owen & Faraz Shafaghi, Creyos
I spoke with neuroscientist Adrian Owen, co-founder and Chief Scientific Officer & Faraz Shafaghi, Chief Product Officer, at neurological testing company Creyos (which rhymes with “chaos”). Their cognitive assessment platform gives a baseline of neurological function and is essentially getting objective data at a point of care. This can now be done as part of…
